Gotham Asset Management »

Arbutus Biopharma shares owned by Gotham Asset Management

Quarter-by-quarter ownership of Arbutus Biopharma (ABUS) shares owned by Gotham Asset Management from 13F filings

Historical chart of Gotham Asset Management investment in Arbutus Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Arbutus Biopharma held by Gotham Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arbutus Biopharma by Gotham Asset Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $78k 17k 4.50

More positions owned by Gotham Asset Management

State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Tidal Trust I Gotham Enhncd (GSPY)
Ishares Tr Core S&p500 Etf (IVV)
Vanguard Index Fds Value Etf (VTV)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Snowflake Com Shs (SNOW)
Ishares Tr 0-3 Mnth Treasry (SGOV)
Ishares Tr Core Msci Eafe (IEFA)
Microsoft Corporation (MSFT)
Ishares Tr Russell 3000 Etf (IWV)
Broadcom (AVGO)

View all positions for Gotham Asset Management

Top funds holding Arbutus Biopharma

Morgan Stanley
Two Seas Capital
Whitefort Capital Management
BlackRock
Vanguard Group
Vanguard Capital Management
Rubric Capital Management
State Street Corporation
Adage Capital Partners GP
Geode Capital Management
ADAR1 Capital Management
Legal & General Group
Woodline Partners
Leucadia National Corporation
BlackBarn Capital Partners

View all funds holding Arbutus Biopharma